We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+25.8%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.29B
AUM Growth
+$290M
Cap. Flow
+$53.6M
Cap. Flow %
4.15%
Top 10 Hldgs %
55.08%
Holding
1,109
New
59
Increased
171
Reduced
182
Closed
40

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$13.2M
2
MSFT icon
Microsoft
MSFT
+$12.7M
3
V icon
Visa
V
+$7.78M
4
MA icon
Mastercard
MA
+$4.67M
5
AMAT icon
Applied Materials
AMAT
+$4.67M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$16M
2
IDXX icon
Idexx Laboratories
IDXX
+$2.62M
3
ADBE icon
Adobe
ADBE
+$2M
4
MCD icon
McDonald's
MCD
+$1.75M
5
INTU icon
Intuit
INTU
+$1.63M

Sector Composition

Rank Sector Weight
1 Technology 24.35%
2 Financials 22.24%
3 Consumer Discretionary 18.99%
4 Communication Services 11.15%
5 Healthcare 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLIR
1001
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$811 ﹤0.01%
+20
New +$830
NAGE
1002
Niagen Bioscience
NAGE
$260M
$762 ﹤0.01%
166
AIG.WS
1003
DELISTED
American International Group, Inc.
AIG.WS
$743 ﹤0.01%
531
NE
1004
DELISTED
Noble Corporation
NE
$737 ﹤0.01%
2,294
GNMK
1005
DELISTED
GenMark Diagnostics, Inc
GNMK
$736 ﹤0.01%
50
INMD icon
1006
InMode
INMD
$855M
$708 ﹤0.01%
50
+28
+127% +$374
PBR icon
1007
Petrobras
PBR
$119B
$695 ﹤0.01%
84
ARLP icon
1008
Alliance Resource Partners
ARLP
$3.37B
$691 ﹤0.01%
212
NBRV
1009
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$675 ﹤0.01%
4
TRIP icon
1010
TripAdvisor
TRIP
$1.16B
$665 ﹤0.01%
+35
New +$669
ADNT icon
1011
Adient
ADNT
$1.47B
$657 ﹤0.01%
40
MOS icon
1012
The Mosaic Company
MOS
$7.5B
$651 ﹤0.01%
52
RRD
1013
DELISTED
RR Donnelley & Sons Co.
RRD
$634 ﹤0.01%
533
SFL icon
1014
SFL Corp
SFL
$1.72B
$632 ﹤0.01%
68
PRGO icon
1015
Perrigo
PRGO
$2.01B
$608 ﹤0.01%
11
-7
-39% -$369
SPXU icon
1016
ProShares UltraPro Short S&P 500
SPXU
$387M
$602 ﹤0.01%
1
VAL
1017
DELISTED
Valaris plc Class A Ordinary Share
VAL
$601 ﹤0.01%
922
XONE
1018
DELISTED
The ExOne Company
XONE
$599 ﹤0.01%
70
JMIA
1019
Jumia Technologies
JMIA
$865M
$549 ﹤0.01%
100
SER icon
1020
Serina Therapeutics
SER
$62.5M
$540 ﹤0.01%
16
TURN
1021
DELISTED
180 Degree Capital
TURN
$539 ﹤0.01%
103
GROW icon
1022
US Global Investors
GROW
$41.3M
$513 ﹤0.01%
270
CHGA
1023
Change Agents Corp
CHGA
$2.84M
$475 ﹤0.01%
2
VIAV icon
1024
Viavi Solutions
VIAV
$9.02B
$471 ﹤0.01%
37
DDD icon
1025
3D Systems Corp
DDD
$545M
$419 ﹤0.01%
60

Similar funds

RBC Europe's Q2 2020 Portfolio in Review

As of Q2 2020, RBC Europe held 1,109 positions worth $1.29B, up 29% from $1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

RBC Europe deployed $53.6M of net new capital in Q2 2020, opening 59 new positions and adding to 171 existing holdings. Its largest new stake was S&P Global: 6,016 shares worth $1.98M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $16M trimmed.

  • RBC Europe's largest Q2 2020 buy was S&P Global: 6,016 shares worth $1.98M.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2020, an estimated $13.2M increase.
  • RBC Europe's biggest Q2 2020 reduction was Tesla, cutting an estimated $16M.
  • RBC Europe fully exited Raytheon Company in Q2 2020, selling an estimated $558K.
  • RBC Europe's ten largest holdings make up 55% of its $1.29B portfolio in Q2 2020.
  • RBC Europe opened 59 new positions and closed 40 in Q2 2020.
  • RBC Europe's portfolio value rose 29% quarter-over-quarter to $1.29B.

Based on RBC Europe's 13F filing for Q2 2020, filed 9 Nov 2023.